Croner Roland S, Guenther Klaus, Foertsch Thomas, Siebenhaar Renate, Brueckl Wolfgang M, Stremmel Christian, Hlubek Falk, Hohenberger Werner, Reingruber Bertram
Department of Surgery, University of Erlangen, Germany.
J Lab Clin Med. 2004 Jun;143(6):344-51. doi: 10.1016/j.lab.2004.03.003.
Colorectal-carcinoma specimens are heterogeneous and include areas of nonmalignant mucosal and connective tissue. For those study designs in which laser microdissection and RNA preamplification are impracticable, the optimal yield of genuine cancer RNA is a key factor in gene-expression analysis. In this study we compared alternative methods of tissue purification. Three contiguous 0.5-cm(3) samples taken from an advanced primary adenocarcinoma of the sigmoid colon were processed immediately after surgery with the use of the following methods: (1) cryotomy after manual dissection (CMD), (2) microscopically assisted manual dissection (MAMD), and (3) tumor-cell isolation with the use of Ber-EP4 antibodies and Dynabeads (Dynal Biotech GmbH, Hamburg, Germany; technique abbreviated as DB). We generated gene-expression profiles with the use of GeneChip technology (Affymetrix, Santa Clara, Calif) and recorded preparation times, costs, and RNA quantity and quality. CMD took 60 minutes, MAMD 180 minutes, and DB 90 minutes to isolate 22, 8, and 23 microg of RNA, respectively. Expenses for materials amounted to 41, 23, and 91 US dollars for CMD, MAMD, and DB, respectively. The 3'/5' ratio, as determined with the GeneChips, for GAPDH/beta-actin was 1.01:1.03 for CMD, 1.13:1.28 for MAMD, 1.43:1.68 for DB, K-ras, APC, smad 2, transforming growth factor-beta, and p53 were marked as present in all cases, with the exception of APC, which was graded as marginal on DB. The correlation values of gene-expression profiles were 91% (CMD/DB), 93% (CMD/MAMD), and 97% (DB/MAMD). All 3 methods provided enough RNA, of sufficient quality, for gene-expression microarray analysis in colorectal carcinoma. Cross-methodologic analyses of array data should not be performed uncritically.
结直肠癌标本具有异质性,包括非恶性黏膜和结缔组织区域。对于那些无法进行激光显微切割和RNA预扩增的研究设计,获得真正的癌RNA的最佳产量是基因表达分析中的关键因素。在本研究中,我们比较了组织纯化的替代方法。从乙状结肠晚期原发性腺癌中获取三个连续的0.5立方厘米样本,术后立即采用以下方法进行处理:(1)手动解剖后冷冻切片(CMD),(2)显微镜辅助手动解剖(MAMD),以及(3)使用Ber-EP4抗体和磁珠(德国汉堡的Dynal Biotech GmbH;技术简称为DB)分离肿瘤细胞。我们使用基因芯片技术(Affymetrix,加利福尼亚州圣克拉拉)生成基因表达谱,并记录制备时间、成本以及RNA的数量和质量。CMD分离22微克RNA用时60分钟,MAMD分离8微克RNA用时180分钟,DB分离23微克RNA用时90分钟。CMD、MAMD和DB的材料费用分别为41美元、23美元和91美元。用基因芯片测定的GAPDH/β-肌动蛋白的3'/5'比值,CMD为1.01:1.03,MAMD为1.13:1.28,DB为1.43:1.68。除了在DB上APC分级为临界外,所有病例中K-ras、APC、smad 2、转化生长因子-β和p53均显示存在。基因表达谱的相关值分别为91%(CMD/DB)、93%(CMD/MAMD)和97%(DB/MAMD)。所有这三种方法都能提供足够质量的RNA用于结直肠癌的基因表达微阵列分析。不应不加批判地进行阵列数据的跨方法分析。